About
Miromatrix develops bioengineered human organs for transplantation by removing pig cells from organs and repopulating the remaining matrix with human cells using proprietary perfusion decellularization and recellularization technology.
Explore Miromatrix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.